Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set

被引：1

作者：

Sharma, Raman ^{[1
]}

Chen, Chao ^{[4
]}

Fita, Ioana-Gabriela ^{[5
]}

Gibson, Rachel A. ^{[2
]}

Jones, Sion ^{[6
]}

Pingle, Anup ^{[8
]}

Rolfe, Katie ^{[3
]}

Sharma, Hema

Bird, Panayota ^{[7
]}

机构：

[1] GSK, Clin Pharmacol Modelling & Simulat, Stevenage, Herts, England

[2] GSK, Global Hlth Med R&D, Stevenage, Herts, England

[3] GSK, Biostat, Stevenage, Herts, England

[4] GSK, Clin Pharmacol Modelling & Simulat, Brentford, Middx, England

[5] GSK, Safety Evaluat & Risk Management, Brentford, Middx, England

[6] GSK, Clin Safety & Pharmacovigilance, Brentford, Middx, England

[7] GSK, Global Hlth, Brentford, Middx, England

[8] GSK, Global Hlth Access, Mumbai, Maharashtra, India

来源：

INDIAN JOURNAL OF MEDICAL RESEARCH | 2023年 / 158卷 / 02期

关键词：

PREVENT RELAPSE; DOUBLE-BLIND; EFFICACY; PRIMAQUINE; TOLERABILITY; REGIMENS; SAFETY; TRIAL;

D O I：

10.4103/ijmr.ijmr_405_23

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：204 / 206

页数：3

共 20 条

[1] Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers [J].

Ackert, Jessica ;

Mohamed, Khadeeja ;

Slakter, Jason S. ;

El-Harazi, Sherif ;

Berni, Alessandro ;

Gevorkyan, Hakop ;

Hardaker, Elizabeth ;

Hussaini, Azra ;

Jones, Sion W. ;

Koh, Gavin C. K. W. ;

Patel, Jyoti ;

Rasmussen, Scott ;

Kelly, Deborah S. ;

Baranano, David E. ;

Thompson, John T. ;

Warren, Keith A. ;

Sergott, Robert C. ;

Tonkyn, John ;

Wolstenholme, Allen ;

Coleman, Hanna ;

Yuan, Alex ;

Duparc, Stephan ;

Green, Justin A. .

DRUG SAFETY, 2019, 42 (09) :1103-1114

[2] Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel? [J].

Baird, J. Kevin .

JOURNAL OF TRAVEL MEDICINE, 2021, 28 (05)

[3]

Clinical TrialRegistryIndia, TAF112582-A multi-centre, doubleblind, randomised, parallel-group, active-controlled study to evaluate the efficacy, safety and tolerability of tafenoquine (SB-252263,WR238605) in subjects with Plasmodium vivax malaria

[4] The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific [J].

Elmes, N. J. ;

Nasveld, P. E. ;

Kitchener, S. J. ;

Kocisko, D. A. ;

Edstein, M. D. .

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2008, 102 (11) :1095-1101

[5] A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria [J].

Fukuda, Mark M. ;

Krudsood, Srivicha ;

Mohamed, Khadeeja ;

Green, Justin A. ;

Warrasak, Sukhuma ;

Noedl, Harald ;

Euswas, Ataya ;

Ittiverakul, Mali ;

Buathong, Nillawan ;

Sriwichai, Sabaithip ;

Miller, R. Scott ;

Ohrt, Colin .

PLOS ONE, 2017, 12 (11)

[6] Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects [J].

Green, Justin A. ;

Patel, Apurva K. ;

Patel, Bela R. ;

Hussaini, Azra ;

Harrell, Emma J. ;

McDonald, Mirna J. ;

Carter, Nick ;

Mohamed, Khadeeja ;

Duparc, Stephan ;

Miller, Ann K. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (09) :995-1005

[7]

GSK, Highlights of prescribing information

[8]

GSK, US FDA approves krintafel (tafenoquine) for the radical cure of P. vivax malaria

[9] Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019 [J].

Haston, Julia C. ;

Hwang, Jimee ;

Tan, Kathrine R. .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (46) :1062-1068

[10] Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data [J].

Hounkpatin, Aurore B. ;

Kreidenweiss, Andrea ;

Held, Jana .

INFECTION AND DRUG RESISTANCE, 2019, 12 :553-570

← 1 2 →